Notable Analyst Rating Changes 9/5: (IPCI) (CIEN) (BP) Upgraded; (TTWO) (PCLN) (MS) Downgraded
Tweet Send to a Friend
UPGRADES
Maxim Group raises IntelliPharmaCeutics International (Nasdaq: IPCI) from Hold to Buy and moves its price target from $3 up ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Maxim Group raises IntelliPharmaCeutics International (Nasdaq: IPCI) from Hold to Buy and moves its price target from $3 up ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
